RecruitingNCT05067543

Perform Humeral System Study


Sponsor

Stryker Trauma and Extremities

Enrollment

300 participants

Start Date

Sep 12, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

This study is an international, single arm, multicenter, prospective, non-significant risk, Post-Market Clinical Follow-up study, which is designed to collect safety and performance data at baseline, surgery, immediate post-op and annually through 10 years post-operation. Data collected from this study will be used for purposes, including but not limited to, Post-Market Surveillance, peer-reviewed publications, education materials, regulatory submissions, and/or product development.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • years or older at the time of the informed consent or non-opposition (when applicable).
  • Informed and willing to sign an informed consent form approved by IRB or EC (when applicable).
  • Willing and able to comply with the requirements of the study protocol.
  • Considered a candidate for shoulder arthroplasty using a study device.
  • Meets indications for use requirements or other local, regional, or geographic specific regulatory requirements

Exclusion Criteria11

  • Not able to comply with the study procedures based on the judgment of the assessor (e.g. cannot comprehend study questions, inability to keep scheduled assessment times)
  • Patient belongs to a vulnerable group of patients, including minor patients, those unable to decide for themselves to participate or needing a Legally Authorized Representative (LAR), or others who could be subject to coercion (patients who may not be acting on their own initiative) (referred as "vulnerable subject" in the section 3.44 of the ISO 14155 norm).
  • Active local or systemic infection, sepsis, or osteomyelitis
  • Poor bone quality, where there could be considerable migration of the prothesis and/or a chance of fracture of the humerus or glenoid
  • Significant injury to the brachial plexus
  • Inadequate bone stock in the proximal humerus or glenoid fossa for supporting the components
  • Neuromuscular disease (e.g., joint neuropathy)
  • Patient with known allergy to one of the product materials
  • Metabolic disorders which may impair bone formation
  • Patient pregnancy
  • Planned for two-stage surgery

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETornier Perform Humeral - Stem

The PERFORM Humeral System - Stem is a non-constrained prosthesis intended for the total or partial replacement of the glenohumeral articulation.


Locations(10)

Baptist Healthcare

Lexington, Kentucky, United States

Summit Orthopedics

Eagan, Minnesota, United States

Mayo Clinic

Rochester, Minnesota, United States

Washington University

St Louis, Missouri, United States

Orthopedic Institute

Sioux Falls, South Dakota, United States

University of Utah

Salt Lake City, Utah, United States

Roth McFarlane Hand and Upper Limb Centre

London, Ontario, Canada

Orthopedic Center Santy

Lyon, France

Schulthess Klinik

Zurich, Switzerland

Wrightington Hospital

Wigan, Lancashire, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05067543


Related Trials